All In Biotech

Drug Trial Radar · NCT07742553

Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial

A Multisite, Double-blind, Randomized Controlled Trial Comparing Body Composition, Muscle, and Bone Changes to TestosteRone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial

Last checked: Nov 19, 2026Latest source record: Aug 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingPhase 3. Randomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Oct 1, 2027

Primary completion

Sep 30, 2031

Study completion Mar 31, 2032

Sponsor

Lead sponsor
VA Office of Research and DevelopmentFederal agency
Sponsor type
Federal agency
Collaborators
North Florida/South Georgia Veterans Health System; VA Eastern Colorado Health Care System; University of Colorado, Denver; James J. Peters Veterans Affairs Medical Center; James A. Haley Veterans Administration Hospital
First posted
Aug 3, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Supportive care
FDA-regulated drug
Yes
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Spinal cord injury (SCI) results in lower limb muscle loss, bone loss, and high fat mass that impede the recovery of physical function, increase bone fracture risk, and worsen health and quality of life. These deficits result from reduced activity after SCI and may be worsened by low testosterone, which is present in many men with SCI. In older men with low testosterone who do not have SCI, testosterone therapy (TRT) is known to increase muscle mass, muscle strength, and bone mineral density, and to reduce body fat. However, it is not known if TRT is effective in men with SCI. The purposes of this study are to determine the effectiveness of TRT in men who have low testosterone and difficulty walking after chronic motor incomplete SCI and to assess whether a process in the body that changes testosterone to dihydrotestosterone (DHT; another hormone that is stronger than testosterone) impacts the effectiveness of TRT in the impaired lower limbs and in other tissues after SCI. The researchers hypothesize that TRT will improve muscle and bone in the impaired limbs of men with chronic incomplete SCI and reduce fat mass, and that finasteride (a drug that blocks that blocks a process that changes testosterone to DHT) will influence prostate symptoms but not the musculoskeletal or body composition benefits produced by TRT.

Conditions

  • Spinal Cord Injury
  • Spinal Cord Injuries
  • Injuries, Spinal Cord
  • Spinal Cord Contusion
  • Spinal Cord Trauma
  • Trauma, Nervous System
  • Wounds and Injuries
  • Spinal Cord Compression
  • Nervous System Diseases
  • Spinal Cord Diseases
  • Gonadal Disorders
  • Endocrine System Diseases
  • Hypogonadism
  • Genital Diseases, Male

Interventions

  • testosterone cypionateDrug

    Participants receive testosterone (200 mg/q2wk) by intramuscular injection

  • finasterideDrug

    Participants receive finasteride (5 mg/day) orally

  • placebo injectionDrug

    Participants receive placebo (weekly) by intramuscular injection

  • placebo pillDrug

    Participants receive placebo pill (daily) orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in lower limb fat-free massTime frame: Baseline, 9 months

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Rocky Mountain Regional VA Medical Center, Aurora, CO

    Aurora, Colorado

  • North Florida/South Georgia Veterans Health System, Gainesville, FL

    Gainesville, Florida

  • James A. Haley Veterans' Hospital, Tampa, FL

    Tampa, Florida

  • James J. Peters VA Medical Center, Bronx, NY

    The Bronx, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.